Hospira, Inc. recalls Hospira, Novaplus — Labetalol Hydrochloride Injection, USP
- Recall date
- February 23, 2018
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Brand / firm
- Hospira, Inc., Hospira, Novaplus
Why it was recalled
Due to Potential Of Cracked Glass At The Rim Surface Of The Vials — Damage
What was recalled
Labetalol Hydrochloride Injection, USP
Read the official recall notice →
Get recall alerts
Free email alert whenever Hospira, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Hospira, Inc., Hospira, Novaplus